Andre Witkin, MD
Retina Specialist · Boston, MANPI 1285811216
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.7%. Among retina specialist clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $264.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$3K
- AbbVie$3K
- Novartis$3K
- Genentech, Inc.$3K
- Cortigent Inc$3K
- Alcon$2K
- plus $6K from 18 others
Across 21 payments — averaging $45,124 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$827K
- Genentech, Inc.$121K
What the payments were for
- Consulting fees$11,09549%
- Speaking & faculty fees$3,26214%
- Travel & lodging$8654%
- Food & beverage$4,98722%
- Gifts$2,50011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 11 | $3,339 |
| AbbVie(2 entities) | 7 | $3,166 |
| Novartis | 10 | $2,743 |
| Genentech, Inc. | 3 | $2,635 |
| Cortigent Inc | 1 | $2,500 |
| Alcon | 11 | $1,835 |
| Apellis Pharmaceuticals, Inc. | 2 | $1,669 |
| Eyepoint US, Inc. | 1 | $1,620 |
| Bausch & Lomb Americas Inc. | 3 | $1,320 |
| Regeneron | 4 | $508 |
| Alimera Sciences, Inc. | 5 | $283 |
| Neurotech Pharmaceuticals, Inc. | 1 | $234 |
| Regeneron Healthcare Solutions, Inc. | 10 | $231 |
| Astellas Pharma US Inc | 3 | $188 |
| Sandoz | 3 | $103 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Sun Pharmaceutical Industries Inc. | 2 | $57 |
| Amgen(2 entities) | 2 | $50 |
| Coherus Oncology, Inc. | 1 | $35 |
| Oyster Point Pharma, Inc. | 1 | $27 |
| Dompe US, Inc. | 1 | $26 |
| Harrow Eye, LLC | 1 | $24 |
| Sight Sciences, Inc. | 1 | $24 |
| Tarsus Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,709 in reported general payments places this provider in the 90th percentile of 26 retina specialist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 110 | $4,007 |
| Brimonidine Tartrate | 30 | $2,940 |
| Ketorolac Tromethamine | 59 | $732 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 42 | $511 |
| Latanoprost | 65 | $378 |
| Atropine Sulfate | 11 | $250 |
| Timolol Maleate | 18 | $192 |
| ErythromycinErythromycin Base | 13 | $100 |
| Prednisone | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Boston
- Jeffrey HeierBoston$1.5M
- Chirag ShahBoston$14K
- Brian BalliosBoston$3K
- Ilya LeskovBoston$2K
- Siamak ShokrollahiBoston$806
- Omar AbdelalBoston$806
- Xiang WerdichBoston$686
- Mohamed ElmasryBoston$190
- Tina ClearyBoston$184
- Miriam Englander Paschalis IliosBoston$170
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.